These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 38428579)
1. AACAP Endorses the Inclusion of Methylphenidate in the WHO Model Lists of Essential Medicines. Cortese S; Coghill D; Mattingly GW; Rohde LA; Thom RP; Wilens TE; Wong ICK; Faraone SV J Am Acad Child Adolesc Psychiatry; 2024 Jul; 63(7):663-665. PubMed ID: 38428579 [TBL] [Abstract][Full Text] [Related]
2. ESCAP endorses the inclusion of methylphenidate in the WHO model lists of essential medicines and in the Union list of critical medicines. Cortese S; Coghill D; Fegert JM; Mattingly GW; Rohde LA; Wong ICK; Faraone SV Eur Child Adolesc Psychiatry; 2024 May; 33(5):1605-1608. PubMed ID: 38662057 [No Abstract] [Full Text] [Related]
3. WHO Essential Medicines List and methylphenidate for ADHD in children and adolescents. Storebø OJ; Ribeiro JP; Lunde C; Gluud C Lancet Psychiatry; 2024 Feb; 11(2):93. PubMed ID: 38245023 [No Abstract] [Full Text] [Related]
4. WHO Essential Medicines List and methylphenidate for ADHD in children and adolescents. Ponnou S; Timimi S; Briffault X; Batstra L; Gøtzsche PC; Gonon F Lancet Psychiatry; 2024 Feb; 11(2):92-93. PubMed ID: 38245022 [No Abstract] [Full Text] [Related]
5. WHO Essential Medicines List and methylphenidate for ADHD in children and adolescents - Authors' reply. Cortese S; Coghill D; Mattingly GW; Rohde LA; Wong ICK; Faraone SV Lancet Psychiatry; 2024 Feb; 11(2):93-95. PubMed ID: 38245024 [No Abstract] [Full Text] [Related]
6. Autonomic correlates at rest and during evoked attention in children with attention-deficit/hyperactivity disorder and effects of methylphenidate. Negrao BL; Bipath P; van der Westhuizen D; Viljoen M Neuropsychobiology; 2011; 63(2):82-91. PubMed ID: 21178382 [TBL] [Abstract][Full Text] [Related]
7. [Neuropsychiatric bases of the methylphenidate-therapy of the attention deficit/hyperactivity disorder (ADHD)]. Huber M; Kirchler E; Niederhofer H; Gruber L Fortschr Neurol Psychiatr; 2007 May; 75(5):275-84. PubMed ID: 17443438 [TBL] [Abstract][Full Text] [Related]
8. Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD). Storebø OJ; Ramstad E; Krogh HB; Nilausen TD; Skoog M; Holmskov M; Rosendal S; Groth C; Magnusson FL; Moreira-Maia CR; Gillies D; Buch Rasmussen K; Gauci D; Zwi M; Kirubakaran R; Forsbøl B; Simonsen E; Gluud C Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD009885. PubMed ID: 26599576 [TBL] [Abstract][Full Text] [Related]
9. Methylphenidate and the cytochrome P450 system. Baird R Can J Psychiatry; 2003 Jul; 48(6):425-6; author reply 426. PubMed ID: 12894619 [No Abstract] [Full Text] [Related]
10. Changes of Heart Rate Variability during Methylphenidate Treatment in Attention-Deficit Hyperactivity Disorder Children: A 12-Week Prospective Study. Kim HJ; Yang J; Lee MS Yonsei Med J; 2015 Sep; 56(5):1365-71. PubMed ID: 26256981 [TBL] [Abstract][Full Text] [Related]
11. An adolescent with kleptomania and attention-deficit/hyperactivity disorder treated with methylphenidate. Hergüner S; Tanidir C J Child Adolesc Psychopharmacol; 2011 Aug; 21(4):383-4. PubMed ID: 21823916 [No Abstract] [Full Text] [Related]
13. Methylphenidate (Ritalin) use and abuse. Crutchley A; Temlett JA S Afr Med J; 1999 Oct; 89(10):1076-9. PubMed ID: 10582063 [No Abstract] [Full Text] [Related]
14. Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders. Osland ST; Steeves TD; Pringsheim T Cochrane Database Syst Rev; 2018 Jun; 6(6):CD007990. PubMed ID: 29944175 [TBL] [Abstract][Full Text] [Related]
16. [Effects of methylphenidate in auditory processing evaluation of children and adolescents with attention deficit hyperactivity disorder]. Cavadas M; Pereira LD; Mattos P Arq Neuropsiquiatr; 2007 Mar; 65(1):138-43. PubMed ID: 17420844 [TBL] [Abstract][Full Text] [Related]
17. [Methylphenidate and sleep: Results of a multicentre study on a population of children with attention deficit hyperactivity disorder]. Tomás Vila M; Aleu Pérez-Gramunt M; Beseler Soto B; Benac Prefasi M; Pantoja Martínez J; Pitarch Castellano I An Pediatr (Barc); 2010 Aug; 73(2):78-83. PubMed ID: 20605120 [TBL] [Abstract][Full Text] [Related]
18. [Efficacy and safety of stimulants and non-stimulants in adults with attention deficit hyperactivity disorder (ADHD)]. Golubchik P; Sever J; Weizman A Harefuah; 2011 Oct; 150(10):788-90, 814. PubMed ID: 22111124 [TBL] [Abstract][Full Text] [Related]
19. Association of the adrenergic alpha2A receptor gene with methylphenidate improvement of inattentive symptoms in children and adolescents with attention-deficit/hyperactivity disorder. Polanczyk G; Zeni C; Genro JP; Guimarães AP; Roman T; Hutz MH; Rohde LA Arch Gen Psychiatry; 2007 Feb; 64(2):218-24. PubMed ID: 17283289 [TBL] [Abstract][Full Text] [Related]
20. The ball search field task in the evaluation of methylphenidate treatment of children with attention deficit / hyperactivity disorder. Rosetti MF; Ulloa E; Mayer P; Palacios-Cruz L; de la Peña FR; Hudson R Psychiatry Res; 2020 Nov; 293():113403. PubMed ID: 32835929 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]